Showing results (231-240 of 364) with videos related to
Sort By:
Pageof 37
American Journal of Cancer Research|March 10, 2023
Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapyHung-Wei Wang, Chi-Yi Chen, Hsueh-Chou Lai, et al.Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|February 9, 2026
Survival Outcome Was Better with Liver Resection than with Percutaneous Radiofrequency Ablation in Patients with Very Early-Stage Hepatocellular Carcinoma: A Single-Center Retrospective StudyYi-Hao Yen, Yueh-Wei Liu, Chao-Hung Hung, et al.Updates in Surgery|October 17, 2025
The association between antiviral therapy and 10-year overall survival of patients undergoing liver resection for hepatitis C virus- or hepatitis B virus-related hepatocellular carcinomaYi-Hao Yen, Yueh-Wei Liu, Chien-Hung Chen, et al.BMC Gastroenterology|March 30, 2012
Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasisChih-Ming Liang, Jyong-Hong Lee, Yuan-Hung Kuo, et al.The American Journal of Tropical Medicine and Hygiene|August 17, 2005
Endoscopic findings and management of dengue patients with upper gastrointestinal bleedingYi-Chun Chiu, Keng-Liang Wu, Chung-Huang Kuo, et al.BMC Gastroenterology|April 18, 2021
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patientsKung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, et al.Oncotarget|December 2, 2017
Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavirChien-Hung Chen, Chuan-Mo Lee, Hsueh-Chou Lai, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2018
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavirHung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, et al.Journal of Gastroenterology and Hepatology|January 14, 2016
Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patientsHsin-Ming Wang, Chao-Hung Hung, Chuan-Mo Lee, et al.International Journal of Cancer|May 10, 2007
Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumorsKuo-Chin Chang, Ming-Hong Tai, Jui-Wei Lin, et al.Pageof 37